This valuable study investigates the role of HIF1a signaling in epicardial activation and neonatal heart regeneration in mice. Using a combination of genetic and pharmacological approaches, the ...
As Europe’s pharmaceutical sector strengthens its focus on specialty intermediates, terephthalic aldehyde has become indispensable for researchers and manufacturers pursuing synthetic versatility, ...
A six-metabolite plasma panel was developed and validated for gastric cancer (GC) diagnosis using UPLC-MS and machine ...
Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages of ...
Germany’s Merck KGaA is paying $45 million upfront for rights to a potentially first-in-class drug for colorectal cancer (CRC) being developed by New York biotech Inspirna. The agreement gives Merck ...
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...
The United States maintains steady progress with 5.0% CAGR, benefiting from high adoption of digital monitoring and advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback